Sheel Biotech Limited (NSE:SHEEL)

Market Cap	936.22M
Revenue (ttm)	1.12B +10.3%
Net Income	146.09M
EPS	9.94
Shares Out	20.35M
PE Ratio	4.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Average Volume	32,000
Open	43.85
Previous Close	42.00
Day's Range	43.85 - 44.10
52-Week Range	37.80 - 95.55
Beta	n/a
RSI	45.14
Earnings Date	Sep 25, 2026

About Sheel Biotech

Sheel Biotech Limited engages in growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants in India. The company offers fruit planting materials, including banana, citrus, pineapple, pomegranate, guava, apple, peach, pear, plum, blueberry, raspberry, strawberry, and other fruit crops; planting material for various forestry species, including bamboo, eucalyptus, poplar, yucca, and others; and various ornamental plants such as bonsai, palms, succulents, and ferns, as well as c...

• Industry: Agricultural Production Crops
• Founded: 1991
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SHEEL

Financial Performance

In fiscal year 2025, Sheel Biotech's revenue was 1.02 billion, an increase of 10.26% compared to the previous year's 922.82 million. Earnings were 106.36 million, an increase of 1.54%.